AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Redyx 100mg Injection

Prescription Icon
Prescription Required

Marketer

Dr Reddy's Laboratories Ltd

Salt Composition

Remdesivir (100mg)

Overview Redyx 100mg Injection

Corova 100mg Injection, a wide-ranging antiviral medication, treats severe COVID-19 in hospitalized adults and children, whether clinically suspected or lab-confirmed. This injectable formulation reduces viral burden and accelerates recovery. Corova 100mg Injection's mechanism involves RNA polymerase inhibition, a key enzyme in SARS-CoV-2 replication. Administered intravenously under medical supervision, it requires a physician's prescription, adhering strictly to the prescribed dosage and duration. Self-medication is strictly prohibited. Common adverse effects may include anemia, pyrexia, acute renal failure, hyperglycemia, and elevated liver enzymes. Report any allergic reactions or concerning side effects to your physician immediately. Disclose pregnancy or breastfeeding status to your doctor. Use caution when administering to elderly or pediatric patients.

Primary Ingredients of Redyx 100mg Injection

The provided text is "undefined," therefore no rewriting is possible.

Uses of Redyx 100mg Injection

Managing Coronavirus Infection (COVID-19)

Major Benefits of Redyx 100mg Injection:

This medication will be administered by your physician or their designated nurse; please do not attempt self-medication.

Common Side effects of Redyx 100mg Injection:

  • Headache
  • Rash
  • Extravasation
  • Increased prothrombin time
  • Increased transaminase level in blood

How to use Redyx 100mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Redyx 100mg Injection works:

Inhibix 100mg Injection, a wide-ranging antiviral agent, targets the viral RNA polymerase enzyme. This enzyme is crucial for SARS-CoV-2 replication; Inhibix's action effectively reduces the virus's ability to reproduce, thereby lowering its concentration within the patient.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Redyx 100mg Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Redyx 100mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Redyx 100mg Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Redyx 100mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Redyx 100mg Injection's efficacy and safety in individuals with renal impairment. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Redyx 100mg Injection to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Redyx 100mg Injection :

NA

Facts to Know About Redyx 100mg Injection

LabelValue
Chemical Type Amino acid alkyl esters
Developing Habits No.
Treatment Category Antimicrobial Agents

FAQs on Redyx 100mg Injection

COVID-19, caused by the novel SARS-CoV-2 virus, is a highly contagious respiratory illness. This newly emerged virus primarily affects the lungs, causing symptoms such as fever, cough, and shortness of breath.
Redyx 100mg Injection, an antiviral medication, demonstrated effectiveness in managing severe COVID-19 in recent laboratory studies of hospitalized patients. While not yet approved for COVID-19 treatment, some studies indicate faster recovery in patients receiving Redyx 100mg Injection compared to other treatments. However, its safety and efficacy in treating COVID-19 require further investigation, with ongoing clinical trials underway.
The Food and Drug Administration (FDA), under the Food, Drug, and Cosmetic Act, issues Emergency Use Authorizations (EUAs) for medical products (medicines, vaccines, or devices) to diagnose, treat, or prevent serious conditions like COVID-19 during public health emergencies. While not full approvals, EUAs allow use when the benefits outweigh the risks.
Redyx 100mg Injection is administered intravenously by a doctor only to hospitalized children and adults with severe COVID-19. Severe COVID-19 is defined as SpO2 ≤94% on room air, or requiring supplemental oxygen, mechanical ventilation, or ECMO. Self-administration is prohibited. Always follow your doctor's instructions for optimal results.
The EU has authorized Redyx 100mg Injection for hospitalized patients with suspected or confirmed severe COVID-19, demonstrating accelerated recovery from severe respiratory distress in both adult and pediatric populations.
Ongoing clinical trials are evaluating Redyx 100mg Injection. Preliminary findings suggest it inhibits SARS-CoV-2 replication, reducing viral load and potentially accelerating recovery from COVID-19.
Redyx 100mg Injection may cause anemia, fever, kidney damage, nausea, vomiting, chills, sweating, low blood pressure, and elevated liver enzymes. Further side effects are possible, and research into Redyx 100mg Injection, including its use in treating COVID-19, is ongoing. Therefore, additional risks may exist.
Limited data supports the safety and efficacy of Redyx 100mg Injection for treating hospitalized adults and children with severe COVID-19. Its use is authorized only after careful consideration of potential benefits versus risks, with ongoing clinical trials currently evaluating its safety.
Limited data exists on Redyx 100mg Injection's use in COVID-19 treatment. Its safety and effectiveness in pregnant or breastfeeding individuals are unknown. If you are pregnant, breastfeeding, or planning pregnancy, consult your doctor immediately if you have or suspect a COVID-19 infection. They will determine the appropriate course of action based on your individual circumstances.
Inform your doctor of all health conditions, including kidney or liver problems, serious illnesses like heart disease or diabetes, and allergies, before receiving Redyx 100mg Injection. Disclose all medications—prescription, over-the-counter, vitamins, or herbal products—as Redyx 100mg Injection's effects may be altered by, or alter, other medicines, particularly those containing chloroquine phosphate or hydroxychloroquine sulfate. Also, tell your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Redyx 100mg Injection is not indicated for COVID-19 prevention; its efficacy in this context is unsupported by data.
The Drug Controller General of India (DCGI) has granted emergency authorization for Redyx 100mg Injection due to the pandemic. Its use is restricted to confirmed COVID-19 patients with a demonstrated clinical need; it is not approved for preventative use or suspected cases.
Redyx 100mg Injection
2,078
MRP 2,531
17% off